SeekingAlpha · Sep 26, 2026
THQ: A 5.6% Cut Leaves An 11% Yield, But Payouts Now Follow NAV
Abrdn Healthcare Opportunities Fund (THQ) adopts a 10% variable distribution tied to NAV; assess payout sustainability, discount and leverageâread now.
TH
NYSE · THQ
Abrdn Healthcare Opportunities Fund
Financial Services · Asset Management
$19.02
Up+$0.68 (+3.71%)
Updated Nov 5, 2026, 4:41 AM
SID Score
4.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 771.31M
- P/E ratio
- 147.32
- Dividend yield
- 12.30%
- 52-week range
- $16.28 – $20.12
- Volume
- 148.15K
- Avg. volume
- 184.97K
Price performance · THQ
THQ price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
THQ closed at $19.02 after 21 trading sessions, up 8.56% for the selected period.
- Last close
- $19.02
- Period change
- +8.56%
- Period low
- $17.45
- Period high
- $19.02
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $18.69 | $19.11 | $18.67 | $19.02 | 148.15K |
| Nov 3, 2026 | $18.32 | $18.672 | $18.30 | $18.34 | 132.98K |
| Nov 2, 2026 | $18.65 | $18.8399 | $18.395 | $18.43 | 109.24K |
| Oct 30, 2026 | $18.98 | $19.06 | $18.66 | $18.71 | 158.27K |
| Oct 29, 2026 | $18.74 | $18.97 | $18.6301 | $18.72 | 167.96K |
| Oct 28, 2026 | $18.24 | $18.6019 | $18.24 | $18.50 | 50.6K |
| Oct 27, 2026 | $18.33 | $18.465 | $18.205 | $18.46 | 80.39K |
| Oct 26, 2026 | $18.26 | $18.565 | $18.20 | $18.29 | 96.62K |
| Oct 23, 2026 | $18.65 | $18.7399 | $18.29 | $18.38 | 89.27K |
| Oct 22, 2026 | $18.71 | $18.88 | $18.65 | $18.80 | 119.98K |
| Oct 21, 2026 | $18.54 | $18.72 | $18.54 | $18.71 | 81.59K |
| Oct 20, 2026 | $18.22 | $18.6699 | $18.1845 | $18.64 | 140.81K |
| Oct 19, 2026 | $17.93 | $18.14 | $17.9032 | $18.06 | 124.18K |
| Oct 16, 2026 | $18.19 | $18.19 | $17.90 | $17.93 | 118.35K |
| Oct 15, 2026 | $17.85 | $18.16 | $17.8273 | $18.11 | 121.86K |
| Oct 14, 2026 | $17.58 | $17.7999 | $17.58 | $17.74 | 143.64K |
| Oct 13, 2026 | $18.00 | $18.01 | $17.60 | $17.60 | 103.07K |
| Oct 12, 2026 | $17.94 | $17.95 | $17.7201 | $17.86 | 78.69K |
| Oct 9, 2026 | $17.41 | $17.89 | $17.25 | $17.86 | 181.16K |
| Oct 8, 2026 | $17.535 | $17.535 | $17.17 | $17.45 | 180.81K |
| Oct 7, 2026 | $17.37 | $17.74 | $17.33 | $17.52 | 91.94K |
Latest THQ news
The latest Smart Investors Daily articles mentioning THQ.
Stock researchCompany · Overview
Company
Market Activity
Research & News
THQ research
Overview
Company profile and research snapshot.
Company profile
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Aug 27, 2026
THQ Offers High-Yield Income From Healthcare Stocks (Rating Upgrade)
abrdn Healthcare Opportunities Fund upgraded: 10.9% yield, -4.5% NAV discount, good distribution coverage and healthcare rebound potential. Click for a THQ update.
SeekingAlpha · Aug 26, 2026
abrdn Healthcare Opportunities Fund Q2 2026 Commentary
The equity portion of the abrdn Healthcare Opportunities Fund gained (gross of fees) and outperformed its benchmark.
SeekingAlpha · Aug 24, 2026
Healthcare Is Rising: XLV Is A Better Option For Investors Than BME
BMEâs gains stem from a shrinking NAV discount, not alpha.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
